Your browser doesn't support javascript.
loading
WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas.
Aavikko, Mervi; Kaasinen, Eevi; Andersson, Noora; Pentinmikko, Nalle; Sulo, Päivi; Donner, Iikki; Pihlajamaa, Päivi; Kuosmanen, Anna; Bramante, Simona; Katainen, Riku; Sipilä, Lauri J; Martin, Samantha; Arola, Johanna; Carpén, Olli; Heiskanen, Ilkka; Mecklin, Jukka-Pekka; Taipale, Jussi; Ristimäki, Ari; Lehti, Kaisa; Gucciardo, Erika; Katajisto, Pekka; Schalin-Jäntti, Camilla; Vahteristo, Pia; Aaltonen, Lauri A.
Afiliação
  • Aavikko M; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Kaasinen E; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Andersson N; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, FI-00014 Helsinki, Finland.
  • Pentinmikko N; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Sulo P; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Donner I; Department of Pathology, Medicum, University of Helsinki, FI-00014 Helsinki, Finland.
  • Pihlajamaa P; Institute of Biotechnology, Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, FI-00014 Helsinki, Finland.
  • Kuosmanen A; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Bramante S; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Katainen R; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Sipilä LJ; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Martin S; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Arola J; Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
  • Carpén O; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Heiskanen I; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Mecklin JP; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Taipale J; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Ristimäki A; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Lehti K; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Gucciardo E; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Katajisto P; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Schalin-Jäntti C; Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Vahteristo P; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland.
  • Aaltonen LA; Department of Pathology, HUSLAB, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.
Hum Mol Genet ; 30(24): 2429-2440, 2021 11 30.
Article em En | MEDLINE | ID: mdl-34274970

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Adenoma / Tumores Neuroendócrinos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Adenoma / Tumores Neuroendócrinos Idioma: En Ano de publicação: 2021 Tipo de documento: Article